1.Villous adenoma of the duodenum: diagnosis and management
Journal of Practical Medicine 2002;435(11):44-47
Villous adenoma is common in the segment 2 of the duodenum. It commonly developed in people at age of 60 years. Diagnosis was made base on findings of gastrointestinal radiography, endoscopy and biopsy. If it is possible, should perform endoscopic ultrasound, duodenopancreatic CT scan and collect several biopsy specimens to determine the surgical approach: duodenopancreatic mass removal, duodenectomy, duodenostomy with tumor removal or endoscopic tumor removal
Adenoma
;
Duodenal Neoplasms
2.Three Cases of Coexistence of Gastric Cancer and Duodenal Ulcer.
In Sik CHUNG ; Soo Hyuk OH ; Chang Seop KIM ; Seung Joon KIM ; Jae Kwang KIM ; Sung Hun WE ; Do Jun MIN ; Eun Jung LEE
Korean Journal of Gastrointestinal Endoscopy 1995;15(1):85-90
Both duodenal ulcer and gastric cancer are common, and it is well known that the pathophysiology of the two is different. The presence of a duodenal ulcer is believed to protect against the development of a gastric malignancy. However gastric cancer may occur in the presence of active or chronic duodenal ulcer disease. Although rare in incidence of coexistence of duodenal ulcer and gastric cancer, physician must be alert to the strange association of duodenal ulcer and gastric cancer. Here, we present 3 cases with coexistence of duodenal ulcer and gastric cancer, diagnosed by endoscopy.
Duodenal Ulcer*
;
Endoscopy
;
Incidence
;
Stomach Neoplasms*
3.Duodenal medullary carcinoma: report of a case.
Jing WANG ; Yuchun MIAO ; Xuanqin YANG ; Enwei XU ; Fang CHANG ; Ning ZHANG
Chinese Journal of Pathology 2015;44(12):916-917
4.A Case of Multiple Primary Cancer in Stomach and Duodenum.
Young Ran SEONG ; Tae Young LEE ; Jae Kyeong LEE ; Mi Kyoung PARK ; Wan Su KIM ; Tae Hun KWON ; Jin Hong PARK ; Seul Young YOON ; Mi Hye CHUNG ; Seong Ho CHOI ; Hye Jin LEE
Korean Journal of Gastrointestinal Endoscopy 1997;17(6):815-820
Double primary cancer is defined as the case of primary malignant tumors of different site origins, which are different histologically in each other. The number of reported cases of multiple primary malignant tumors has increased in recent years, of more developed diagnostic procedure and long survival of cancer patients. Malignant tumors of the small bowel are reported to account for about 1% of all gastrointestinal carcinomas. We have experienced a case with double primary malignant tumors of gastric adenocarcinoma and duodenal adenocarcinoma. For its great rarity, we report this case with review of literatures.
Adenocarcinoma
;
Duodenal Neoplasms
;
Duodenum*
;
Humans
;
Stomach Neoplasms
;
Stomach*
5.The Detection Rate of H. pylori and Intestinal Metaplasia in the Antrum and in the Body.
Na Young KIM ; Jae Jung KO ; Young Hee KO ; Ju Hyun OH ; Chang Gyun LEE ; Sun Hee LIM ; Kye Heui LEE ; Shin Yeun CHOI
Korean Journal of Gastrointestinal Endoscopy 1999;19(1):9-17
AIMS: In this paper we have investigated the detection rate of each H. pylori test in the antrum and in the body for patients with nonulcer dyspepsia (NUD), duodenal ulcer (DU), benign gastric ulcer (BGU), and stomach cancer. In addition, we examined whether or not there is any relationship between the decrease of H. pylori detection rate and intestinal metaplasia in the antrum. METHODS: Three different test methods for identifying H. pylori infection-CLOtest, Gram stain, H&E stain-were taken in the antrum and in the body. RESULTS: 1) The detection rates of CLOtest, Gram stain, and H&E stain for NUD group were 88%, 75%, and 64% (mean: 76%) in the antrum, and 89%, 78%, and 67% (mean: 78%) in the body, respectively, and those of DU group were 95%, 95% and 81% (mean: 90%) in the antrum, and 97%, 87% and 64% (mean: 83%) in the body, respectively. Those of BGU group were 86%, 74%, 53% (mean: 71%) and 98%, 82%, 58% (mean: 79%), respectively, and those of stomach cancer group were 80%, 88%, 58% (mean: 75%) in the antrum, and 100%, 96%, 83% (mean: 93%) in the body, respectively. The B/A detection ratio which means the ratio of mean H. pylori detection rate of body to that of antrum was 1.03 in NUD, 0.93 in DU, 1.11 in BGU, and 1.24 in stomach cancer group. 2) The rate of intestinal metaplasia in the antrum was 12% for NUD, and 15% for DU group. Those of BGU and stomach cancer group were 47% and 72%, respectively. 3) The correlation etween B/A detection ratio and intestinal metaplasia in the antrum was good (correlation coefficient(r)=0.93). CONCLUSIONS: The result that body is more adequate for H. pylori detection in BGU and stomach cancer patients rather than antrum can be explained by the high rate of intestinal metaplasia in the antrum which is hostile surrounding for H. pylori.
Duodenal Ulcer
;
Dyspepsia
;
Humans
;
Metaplasia*
;
Stomach Neoplasms
;
Stomach Ulcer
6.Gangliocytic paraganglioma of the duodenum: a case report.
Guo-Cong WU ; Kang-Li WANG ; Zhong-Tao ZHANG
Chinese Medical Journal 2012;125(2):388-389
Gangliocytic paraganglioma of the duodenum is an extremely rare disease. Few cases have been reported in the literature from 1957 to 2010. We reported a 67-year-old man with gangliocytic paraganglioma of the duodenum.
Aged
;
Duodenal Neoplasms
;
diagnosis
;
Duodenum
;
pathology
;
Humans
;
Male
;
Paraganglioma
;
diagnosis
7.Diagnosis and treatment of duodenal gastrointestinal stromal tumors.
Tong LIU ; Weidong LI ; Weijun TIAN
Chinese Journal of Gastrointestinal Surgery 2015;18(4):316-320
In order to promote clinical capability on duodenal gastrointestinal stromal tumor(GIST), literature review and experience summary were documented in this paper. Duodenal GIST is not rare in clinical practice. With the similar pathologic conditions, GIST in duodenum present a higher malignant risk than that in stomach. The cases who would receive imatinib mesylate as preoperative therapy require a precise preoperative diagnosis obtained by endoscopic ultrasound and fine needle aspiration cytology. Therapeutic strategy should be based on surgical R0 resection with clear margins, preserving pancreatic function and avoiding adjacent organs resection when possible. Limited resection is appropriate and results in similar oncological outcome compared with extensive procedure in suitable cases.
Duodenal Neoplasms
;
Endosonography
;
Gastrointestinal Stromal Tumors
;
Humans
;
Neoadjuvant Therapy
;
Stomach
8.A Case of Obstructive Jaundice after Insertion of Metallic Stent for Duodenal Obstruction by Recurrent Duodenal Ulcer.
Jin Kwang LEE ; Sang Jong PARK ; Kwang Hyun RYU ; Sang Bae LEE ; Hoi Jin KIM ; Hyun Seung JEONG ; Jin Kyung RYU
Korean Journal of Gastrointestinal Endoscopy 2004;28(4):213-217
Insertion of self-expandable metallic stent has been performed as a palliative therapeutic modality for cases with gastrointestinal obstruction caused by inoperable malignancies such as pancreatic cancer, stomach cancer, and cholangiocarcinoma. Although the clinical efficacy is not established yet, it can also be performed for benign gastroduodenal obstruction. Especially, when balloon dilatation is failed and patients are at high risk for surgery or general anesthesia, and when patients refuse operation, insertion of metallic stent can be considered. Complications of this therapeutic modality include intestinal perforation, hemorrhage, migration or malposition of metallic stent, and occlusion of stent by ingrowth and overgrowth of tumor or impaction of food. We report a rare case of obstructive jaundice developed after the insertion of gastroduodenal stent for duodenal obstruction caused by recurrent duodenal ulcer.
Anesthesia, General
;
Cholangiocarcinoma
;
Dilatation
;
Duodenal Obstruction*
;
Duodenal Ulcer*
;
Hemorrhage
;
Humans
;
Intestinal Perforation
;
Jaundice
;
Jaundice, Obstructive*
;
Pancreatic Neoplasms
;
Stents*
;
Stomach Neoplasms
9.Heterotopic Pancreas Presented as Duodenal Tumor with Obstruction.
Pediatric Gastroenterology, Hepatology & Nutrition 2015;18(4):280-285
Heterotopic pancreas (HP) is defined as pancreatic tissue lacking anatomic and vascular continuity with the main body of the pancreas. Most are asymptomatic, but can cause ulcer, bleeding, intussusception, and mechanical obstruction. Herein, we presented one case of HP presented as duodenal tumor causing duodenal obstruction. A 7-year-old girl visited the emergency room for abdominal pain with vomiting for 24 hours. Computed tomography and upper gastrointestinal series revealed a polypoid mass with short stalk in the 2nd portion of duodenum. We attempted an endoscopic removal. However, the lumen was nearly obstructed by the mass and the stalk was too broad and hard to excise. The mass was surgically removed via duodenotomy. It was confirmed as a HP with ductal and acini components (type 2 by Heinrich classification). Postoperatively, the patient has been well without any complication and recurrence.
Abdominal Pain
;
Child
;
Duodenal Neoplasms
;
Duodenal Obstruction
;
Duodenum
;
Emergency Service, Hospital
;
Female
;
Hemorrhage
;
Humans
;
Intussusception
;
Pancreas*
;
Recurrence
;
Ulcer
;
Vomiting
10.A Case of Primary Duodenal Adenocarcinoma Identified by Serially Elevated Serum CEA Levels after Curative Resection for Colon Cancer.
See Jin JANG ; Bo In LEE ; Jeong Seon JI ; Byung Wook KIM ; Hwang CHOI ; Se Hyun CHO ; Kyu Yong CHOI ; Dae Sung KIM ; Min HUH ; Sang Hun LEE ; In Sik CHUNG ; Lee So MAENG
Korean Journal of Gastrointestinal Endoscopy 2005;31(5):339-342
The follow-up of patients after performing potentially curative resection for colon cancer is important, yet the ideal surveillance strategy has not been defined. Periodic clinical examinations, laboratory tests, radiographic imaging, colonoscopy and carcinoembryonic antigen (CEA) testing have been utilized for surveillance, and the serial CEA measurement is the most cost-effective test for identifying the recurrence of disease. However, this test also indicates the development of secondary gastrointestinal malignancy such as gastric cancer or duodenal cancer. We report here on a case of metachronous duodenal adenocarcinoma that was revealed by the serial measurement of the serum CEA after we performed curative resection for colon cancer.
Adenocarcinoma*
;
Carcinoembryonic Antigen
;
Colon*
;
Colonic Neoplasms*
;
Colonoscopy
;
Duodenal Neoplasms
;
Follow-Up Studies
;
Humans
;
Recurrence
;
Stomach Neoplasms